AdaptHealth (AHCO) Likely to Benefit from Medicare Reimursement Increases - Jefferies
Tweet Send to a Friend
Jefferies analyst Brian Tanquilut reiterated a Buy rating and $50.00 price target on AdaptHealth (NASDAQ: AHCO) on the belief that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
